Weekly Analysts’ Ratings Changes for R1 RCM (RCM)

A number of firms have modified their ratings and price targets on shares of R1 RCM (NASDAQ: RCM) recently:

  • 3/20/2024 – R1 RCM had its price target lowered by analysts at Canaccord Genuity Group Inc. from $17.00 to $16.00. They now have a “buy” rating on the stock.
  • 3/20/2024 – R1 RCM was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $16.00 price target on the stock.
  • 3/7/2024 – R1 RCM had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $19.00 price target on the stock.
  • 3/5/2024 – R1 RCM had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
  • 3/5/2024 – R1 RCM had its “hold” rating reaffirmed by analysts at Truist Financial Co.. They now have a $16.00 price target on the stock.
  • 3/1/2024 – R1 RCM had its price target raised by analysts at Citigroup Inc. from $14.00 to $16.00. They now have a “buy” rating on the stock.
  • 2/29/2024 – R1 RCM had its price target raised by analysts at KeyCorp from $13.00 to $17.00. They now have an “overweight” rating on the stock.
  • 2/28/2024 – R1 RCM had its “in-line” rating reaffirmed by analysts at Evercore ISI. They now have a $16.00 price target on the stock, up previously from $12.00.
  • 2/28/2024 – R1 RCM had its “equal weight” rating reaffirmed by analysts at Barclays PLC. They now have a $14.00 price target on the stock.
  • 2/26/2024 – R1 RCM had its “outperform” rating reaffirmed by analysts at Leerink Partnrs.
  • 2/26/2024 – R1 RCM is now covered by analysts at SVB Leerink LLC. They set an “outperform” rating and a $14.00 price target on the stock.

R1 RCM Price Performance

Shares of NASDAQ:RCM opened at $13.00 on Monday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.83 and a current ratio of 1.83. The stock’s fifty day simple moving average is $11.79 and its two-hundred day simple moving average is $11.93. R1 RCM Inc. has a 1-year low of $8.87 and a 1-year high of $18.70.

Insider Transactions at R1 RCM

In other R1 RCM news, President John M. Sparby sold 10,046 shares of R1 RCM stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $14.33, for a total transaction of $143,959.18. Following the completion of the transaction, the president now owns 265,986 shares of the company’s stock, valued at approximately $3,811,579.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 37.00% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of R1 RCM by 5.6% during the third quarter. Vanguard Group Inc. now owns 17,940,792 shares of the healthcare provider’s stock valued at $270,368,000 after purchasing an additional 947,310 shares during the period. Capital International Investors increased its holdings in R1 RCM by 0.8% in the 4th quarter. Capital International Investors now owns 8,343,199 shares of the healthcare provider’s stock worth $88,188,000 after buying an additional 67,485 shares in the last quarter. Voss Capital LLC boosted its position in R1 RCM by 553.9% in the fourth quarter. Voss Capital LLC now owns 7,125,000 shares of the healthcare provider’s stock worth $75,311,000 after purchasing an additional 6,035,340 shares during the last quarter. Bank of New York Mellon Corp boosted its position in R1 RCM by 3.4% in the third quarter. Bank of New York Mellon Corp now owns 7,017,700 shares of the healthcare provider’s stock worth $105,757,000 after purchasing an additional 229,104 shares during the last quarter. Finally, Wellington Management Group LLP lifted its position in shares of R1 RCM by 21.1% during the 1st quarter. Wellington Management Group LLP now owns 6,223,742 shares of the healthcare provider’s stock valued at $166,548,000 after buying an additional 1,086,266 shares in the last quarter. Hedge funds and other institutional investors own 61.10% of the company’s stock.

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.

Further Reading

Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with MarketBeat.com's FREE daily email newsletter.